O impacto da crise da Covid-19 no custo da operadora de saúde de capital aberto com o maior número de beneficiários do Brasil

Abstract

Since January 2020 to the present moment (March 2021), Brazil is experiencing an almost collapse of the Unified Health System (SUS), as well as a drastic reduction in activities to improve, due to the pandemic of the new Corona Virus (SARS- CoV-2). As published by the Institute for Supplementary Health Studies (IESS), due to the lack of research, medicines and vaccines and statistics, Covid-19 is one of the major challenges for the health system. Using the single case study method, this paper aims to analyze the variation in health care costs between the pre and post-pandemic periods, in relation to the change in the cost of the provision of reimbursement to SUS, according to the description of the National Health Agency. Supplementary Health (ANS), analyzing the financial impact for the publicly traded health operator with the largest number of beneficiaries in Brazil, in this period. Therefore, in the first moment, a review of the literature on the supplementary health sector, market regulation and the behavior of measures related to the segment during a current pandemic is presented. In the second step, the qualitative analyzes of the issues discussed are exposed, by checking the public databases of ANS and the Securities and Exchange Commission (CVM). Data analysis was performed using Laurence Bardin's Content Analysis technique, as well as through visual information about the time series data on the cost variable, which allowed the Covid-19 start date to be related to the increase or reduction of assistance costs. Affiliations showed an increase in health care costs with an impact on the cash flow related to the pandemic. The results estimated in this study did not observe evidence that demonstrated the relationship between the health care costs (cash) of the largest health operator in Brazil and the variation in the provision of the reimbursement amount to SUS.